PRQR

#6352
ProQR Therapeutics N.V. Ordinary Shares
1.59
+3.25%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
1.59
1.59
Годовой диапазон
1.07
3.10
Дневное изменение
+3.25%
Месячное изменение
-4.79%
6-месячное изменение
-28.05%
Годовое изменение
-32.91%
Предыдущее закрытие
1.54
Open
1.59
Bid
Ask
Low
1.59
High
1.59
Объем
6
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value 20202021202220232024 TTM

ProQR Therapeutics N.V

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.

Новости